What top creators are saying about Collegium Pharmaceutical, Inc.(COLL)
A specialty pharmaceutical company
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Collegium Pharmaceutical, Inc. in the last 30 days yet.
Top creators covering Collegium Pharmaceutical, Inc. (COLL)
The 1 sources with the most insights about Collegium Pharmaceutical, Inc. on Kazuha.
Latest insights about Collegium Pharmaceutical, Inc. (COLL)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Thursday, September 4, 2025
The Chief Medical Officer made his largest-ever sale ($671,000) after a 30% stock price increase, suggesting he is taking profits. His previous sales were followed by significant declines.
Thursday, September 4, 2025
The Chief Medical Officer made his largest-ever sale ($671,000) after a 30% stock price increase, suggesting he is taking profits. His previous sales were followed by significant declines.
Discussed alongside Collegium Pharmaceutical, Inc. (COLL)
Other assets that creators frequently mention in the same content as Collegium Pharmaceutical, Inc..
Frequently asked
Which podcasters and creators cover Collegium Pharmaceutical, Inc. (COLL) the most?
The most active sources covering Collegium Pharmaceutical, Inc. (COLL) on Kazuha are @ceowatcher. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Collegium Pharmaceutical, Inc. (COLL) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Collegium Pharmaceutical, Inc. (COLL) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Collegium Pharmaceutical, Inc. (COLL)?
Creators covering Collegium Pharmaceutical, Inc. (COLL) most frequently also discuss REZI, AFRM, MTB, COTY. See the "Discussed alongside" section above for full asset pages.